Evaluation of the cytotoxic and genotoxic effects by melamine and cyanuric acid co-exposure in human embryonic kidney 293 cells.


Journal

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917

Informations de publication

Date de publication:
2020
Historique:
received: 18 11 2019
accepted: 17 02 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 5 6 2020
Statut: ppublish

Résumé

The melamine and cyanuric acid (CA) complex has been suggested to cause the toxic effects observed in melamine-contaminated food or milk. However, the cytotoxic and genotoxic effects of co-exposure to melamine and CA are not fully clear. Therefore, the cytotoxic effects of melamine and CA were first examined by co-exposure in human kidney 293 cells using the MTT assay. During a 24-h period for the three concentrations tested (0.5, 1, and 5 mg/mL), neither melamine nor CA alone showed significant toxic effects on 293 cells at 0.5 mg/mL, while higher concentrations led to decreased in cell viability. However, co-exposure to several combinations of melamine and CA [100:1, 10:1, 1:10, and 1:100 (v:v), at a final concentration of 0.5 mg/mL] did cause cytotoxicity with higher levels of CA leading to higher cytotoxicity. By contrast, while neither melamine nor CA alone induced phosphorylated-H2AX (γH2AX) foci formation, melamine and CA at a 100:1 ratio induced γH2AX foci 24 h post-treatment. The alkaline comet assay also revealed the presence of DNA damage following melamine and CA co-exposure. In vivo assay also revealed the presence of melamine-CA complex in the kidney. These data indicated that the cytotoxic and genotoxic effects of melamine and CA co-exposure differ from those of melamine or CA alone.

Identifiants

pubmed: 32348426
pii: S0100-879X2020000500612
doi: 10.1590/1414-431x20209331
pmc: PMC7205411
pii:
doi:

Substances chimiques

Triazines 0
cyanuric acid H497R4QKTZ
melamine N3GP2YSD88

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e9331

Références

Regul Toxicol Pharmacol. 2011 Jun;60(1):144-50
pubmed: 21435367
BMC Res Notes. 2014 Feb 08;7:87
pubmed: 24507656
Kidney Int. 2011 Oct;80(7):746-52
pubmed: 21633410
Toxicol Sci. 2008 Nov;106(1):251-62
pubmed: 18689873
Environ Health Perspect. 1986 Nov;69:287-92
pubmed: 3545805
Toxicol Sci. 2012 Apr;126(2):317-24
pubmed: 22228804
Nat Med. 2008 Jan;14(1):55-63
pubmed: 18084301
Chin Med J (Engl). 2009 Feb 5;122(3):243-4
pubmed: 19236797
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Fish Physiol Biochem. 2014 Oct;40(5):1609-19
pubmed: 24952615
Chemosphere. 2019 Jun;224:280-288
pubmed: 30825854
Mutat Res Genet Toxicol Environ Mutagen. 2015 Jan 1;777:62-7
pubmed: 25726176
J Vet Diagn Invest. 2007 Sep;19(5):525-31
pubmed: 17823396
Toxicol In Vitro. 2006 Sep;20(6):959-65
pubmed: 16473493
Biomed Environ Sci. 2014 Aug;27(8):641-5
pubmed: 25189612
Nat Chem Biol. 2015 Oct;11(10):807-14
pubmed: 26344695
Toxicol Lett. 2017 Oct 5;280:181-189
pubmed: 28751210
Toxicol Appl Pharmacol. 2019 May 1;370:184-195
pubmed: 30922832
Environ Sci Pollut Res Int. 2018 Feb;25(4):3301-3312
pubmed: 29149444
Am J Physiol Renal Physiol. 2018 Aug 1;315(2):F199-F210
pubmed: 29592526
Toxicol Appl Pharmacol. 2013 Aug 1;270(3):218-29
pubmed: 22306862
J Vet Diagn Invest. 2007 Nov;19(6):616-24
pubmed: 17998549
J Am Vet Med Assoc. 2007 Apr 15;230(8):1128-9, 1136-8
pubmed: 17501647
Toxicol Pathol. 2009 Dec;37(7):959-68
pubmed: 19801503
Mutagenesis. 2020 Feb 13;35(1):5-18
pubmed: 31294794
Toxicol Appl Pharmacol. 2012 Jul 15;262(2):99-106
pubmed: 22579976
Food Chem Toxicol. 2016 Oct;96:254-62
pubmed: 27523292
Arch Toxicol. 2010 Apr;84(4):301-7
pubmed: 20020103

Auteurs

Xianrong Xu (X)

Department of Prevention Medicine, Hangzhou Normal University School of Medicine, Hangzhou, Zhejiang, China.

Jing Lu (J)

Zhejiang-California International Nanosystems Institute, Hangzhou, Zhejiang, China.

Hongqiang Sheng (H)

Department of Basic Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Long Zhang (L)

Department of Prevention Medicine, Hangzhou Normal University School of Medicine, Hangzhou, Zhejiang, China.

Tieer Gan (T)

Hospital Infection Control Department, Zhejiang Provincial TCM Hospital, Hangzhou, Zhejiang, China.

Jianyun Zhang (J)

Department of Prevention Medicine, Hangzhou Normal University School of Medicine, Hangzhou, Zhejiang, China.

Yuying Xu (Y)

Department of Toxicology, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.

Xinqiang Zhu (X)

Department of Toxicology, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.

Jun Yang (J)

Department of Prevention Medicine, Hangzhou Normal University School of Medicine, Hangzhou, Zhejiang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH